Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | CA9 | Q16790 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8350884 | 1.00 | CA12 (0.37) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL3216165 | 1.00 | CA12 (0.37) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL8354298 | 0.89 | CA12 (0.42) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL942938 | 0.89 | CA12 (0.42) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL17694209 | 0.88 | CA12 (0.36) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL17694214 | 0.88 | CA12 (0.36) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL17696547 | 0.85 | CA12 (0.37) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL9079974 | 0.81 | CA12 (0.38) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL254392 | 0.81 | CA12 (0.38) | CA12CA9CA1CA2CHRM2 | |
| SCHEMBL8355844 | 0.81 | CA12 (0.38) | CA12CA9CA1CA2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7262215-B2 | N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors | NAD AG (DE) | 2007-08-28 | — | — | US | disclosed |
| US-7262215-B2 | N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors | NAD AG (DE) | 2007-08-28 | — | — | US | disclosed |
| WO-2003051887-A1 | N-CARBACYCLE MONOSUBSTITUTED INDOLOCARBAZOLES AS PROTEIN KINASE INHIBITORS | NAD AG (DE) | 2003-06-26 | — | — | WO | disclosed |